P-Gemox

DRUG2 trials

Sponsors

Fudan University, The First Affiliated Hospital with Nanjing Medical University

Conditions

NK-T-Cell Lymphoma, ExtranodalNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Phase 2

Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma

RecruitingNCT06314334

Fudan UniversityNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Start: 2024-03-04End: 2028-12-30Target: 210Updated: 2026-04-09

Phase 3

A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

Not yet recruitingNCT06953739

The First Affiliated Hospital with Nanjing Medical UniversityNK-T-Cell Lymphoma, Extranodal

Start: 2025-05-01End: 2030-12-31Target: 60Updated: 2025-05-01